# Abbott Laboratories: Form 8-K, filed Jul 16, 2026

- Company: [Abbott Laboratories](/companies/abt.md) (CIK 1800)
- Form: 8-K
- Filed: 2026-07-16
- Accepted by EDGAR: Jul 16, 2026, 11:36 ET
- Period: 2026-07-16
- Accession: 0001628280-26-048377
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1800/000162828026048377/abt-20260716.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1800/000162828026048377/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1800/000162828026048377/abt-20260716.htm

Filed Jul 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-048377. Last ingested by Listed: Oct 24, 2026, 14:50 ET. No prices; not investment advice.